Expression changes in arrestin β 1 and genetic variation in catechol-O-methyltransferase are biomarkers for the response to morphine treatment in cancer patients

By                                  

Oncology Reports, Vol. 27, Iss. 5, 2012-01 ,pp. : 1393-1399

Spandidos Publications

Access to resources Recommend Favorite

Germline genetic variation and breast cancer survival: prognostic and therapeutic implications

By Udler Miriam   Pharoah Paul DP  

Future Oncology, Vol. 3, Iss. 5, 2007-10 ,pp. : 491-495

Future Medicine

Access to resources Recommend Favorite

Germline genetic markers for urinary bladder cancer risk, prognosis and treatment response

By Grotenhuis Anne J   Vermeulen Sita H   Kiemeney Lambertus A  

Future Oncology, Vol. 6, Iss. 9, 2010-09 ,pp. : 1433-1460

Future Medicine

Access to resources Recommend Favorite

Association of genetic variation in tamoxifen-metabolizing enzymes with overall survival and recurrence of disease in breast cancer patients

By Nowell Susan  

Breast Cancer Research and Treatment, Vol. 91, Iss. 3, 2005-06 ,pp. : 249-258

Springer Publishing Company

Access to resources Recommend Favorite

Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival

By Varadi Verena   Bevier Melanie   Grzybowska Ewa   Johansson Robert   Enquist Kerstin   Henriksson Roger   Butkiewicz Dorota   Pamula-Pilat Jolanta   Tecza Karolina   Hemminki Kari   Lenner Per   Försti Asta  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 235-245

Springer Publishing Company

Access to resources Recommend Favorite